A

Aier Eye Hospital Group Co Ltd
SZSE:300015

Watchlist Manager
Aier Eye Hospital Group Co Ltd
SZSE:300015
Watchlist
Price: 13.92 CNY 0.22% Market Closed
Market Cap: 129.8B CNY
Have any thoughts about
Aier Eye Hospital Group Co Ltd?
Write Note
Aier Eye Hospital Group Co Ltd
/
Income Statement
/
Cost of Revenue

Aier Eye Hospital Group Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aier Eye Hospital Group Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Cost of Revenue
-¥10.3B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-24%
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Cost of Revenue
-¥2.8B
CAGR 3-Years
-45%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Hengkang Medical Group Co Ltd
SZSE:002219
Cost of Revenue
-¥2.7B
CAGR 3-Years
-7%
CAGR 5-Years
3%
CAGR 10-Years
-26%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Cost of Revenue
-¥4.5B
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
-4%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Cost of Revenue
-¥2B
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Cost of Revenue
-¥1B
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aier Eye Hospital Group Co Ltd
Glance View

Market Cap
129.8B CNY
Industry
Health Care

Aier Eye Hospital Group Co., Ltd., having risen prominently in the medical services sector, narrates a compelling story of growth and innovation. Founded in 2003 and headquartered in Changsha, China, Aier Eye Hospital embodies the vision of providing comprehensive eye care services across the nation and beyond. Its journey began with a singular focus on ophthalmology, and over the years, it meticulously expanded its network, now operating hundreds of specialized eye clinics and hospitals domestically and internationally. This network offers services ranging from basic eye examinations to complex surgeries, such as cataract removal and refractive surgery. The company reached a notable milestone by successfully integrating modern medical technology with a patient-centric service model, ensuring that its facilities are equipped with state-of-the-art technology to deliver high-quality ophthalmic care. Aier Eye Hospital derives its revenue primarily from providing these medical services, supported by strategic acquisitions and partnerships that enhance its spectrum of offerings and geographic footprint. Its business model deftly combines volume-driven profitability with high-quality care, allowing it to maintain a leadership position in the industry. Education and research form additional pillars of its operational strategy; Aier emphasizes the continuous training of its medical staff and engages in research initiatives, thus fostering an environment of innovation that further solidifies its competitive edge. This blend of strategic growth, patient-focused service, and technological advancement enables Aier Eye Hospital Group to not only cater to a growing demand for eye care services but also chart a course of sustained financial health and expansion.

Intrinsic Value
18.07 CNY
Undervaluation 23%
Intrinsic Value
Price
A
What is Intrinsic Value?

See Also

What is Aier Eye Hospital Group Co Ltd's Cost of Revenue?
Cost of Revenue
-10.3B CNY

Based on the financial report for Sep 30, 2024, Aier Eye Hospital Group Co Ltd's Cost of Revenue amounts to -10.3B CNY.

What is Aier Eye Hospital Group Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-24%

Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Aier Eye Hospital Group Co Ltd have been -14% over the past three years , -15% over the past five years , and -24% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.